Ascend Wellness Holdings (AAWH) Depreciation & Amortization (CF) (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Depreciation & Amortization (CF) came in at $18.3 million in Q1 2026, down 0.65% year-on-year from $18.4 million in Q1 2025, and down 10.96% quarter-over-quarter from $20.5 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $18.3 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 0.65% year-over-year to $18.3 million in Q1 2026; TTM through Mar 2026 was $73.4 million, a 7.68% increase from a year earlier, with the FY2025 full-year figure at $73.5 million, up 11.14% from the prior year.
  • Depreciation & Amortization (CF) declined to $18.3 million in Q1 2026 per AAWH's latest filing, from $20.5 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $21.9 million in Q1 2023 and bottomed at $7.3 million in Q2 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $16.4 million (2024), against an average of $14.9 million.
  • Across the five-year window, Depreciation & Amortization (CF) surged 121.22% in 2023 and decreased 25.35% in 2024, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $11.3 million in 2022, then soared by 31.1% to $14.8 million in 2023, then rose by 18.1% to $17.5 million in 2024, then grew by 17.52% to $20.5 million in 2025, then decreased by 10.96% to $18.3 million in 2026.
  • Per Business Quant, the three latest AAWH Depreciation & Amortization (CF) figures stand at $18.3 million (Q1 2026), $20.5 million (Q4 2025), and $16.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn 18.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.28 Mn
Mar 31, 2026 18.28 Mn
Dec 31, 2025 20.53 Mn
Dec 31, 2025 20.53 Mn
Sep 30, 2025 16.77 Mn
Sep 30, 2025 16.77 Mn
Jun 30, 2025 17.83 Mn
Jun 30, 2025 17.83 Mn
Mar 31, 2025 18.40 Mn
Mar 31, 2025 18.40 Mn
Dec 31, 2024 17.47 Mn
Dec 31, 2024 17.47 Mn
Sep 30, 2024 16.63 Mn
Sep 30, 2024 16.63 Mn
Jun 30, 2024 15.68 Mn
Jun 30, 2024 15.68 Mn
Mar 31, 2024 16.38 Mn
Mar 31, 2024 16.38 Mn
Dec 31, 2023 14.79 Mn
Dec 31, 2023 14.79 Mn